Search - tctmd.com

Displaying 41 - 60 of 331

Sort: Relevancy | Date

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

Presentation TCT 2024

TCT 1220: Sequential PCI of a CTO LAD: Investment Procedure

Presenter: Jurij Avramovic

October 29, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Presentation TCT 2024

TCT 1217: LM-LAD PCI in Subacute Anterior STEMI Complicated With Periprocedural Cardiac Arrest Supported With Novel pVAD

Presenter: Jurij Avramovic

October 28, 2024

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Caitlin E. Cox

June 21, 2024

News Conference News NY Valves 2024

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Todd Neale

June 14, 2024

News Conference News NY Valves 2024

National Data Point to Soaring TAVI Rates in Patients Under 65

Michael O'Riordan

June 14, 2024

Presentation NY Valves 2024

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Presenter: Philippe Pibarot

June 07, 2024

Presentation NY Valves 2024

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Presentation NY Valves 2024

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

Presenter: Tsuyoshi Kaneko

June 06, 2024

Presentation NY Valves 2024

Medical Management Post AVR

Presenter: Javed Butler

June 05, 2024

Presentation NY Valves 2024

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Presenter: Parag Goyal

June 05, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Conference News ACC 2024

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

Yael L. Maxwell

April 05, 2024

News Conference News STS 2024

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

Yael L. Maxwell

February 09, 2024

News Conference News STS 2024

SAVR After Failed TAVI on the Rise, With High Mortality

Yael L. Maxwell

February 05, 2024

Presentation CTO Plus 2024 Abstracts On-Demand 2024

Successful CTO LCX PCI with massive periprocedural cardiac tamponade

Presenter: Jurij Avramovic

February 02, 2024

$Novel pVAD-assisted complex CTO-PCI in a patient with reduced left ventricular ejection fraction$

Presentation CTO Plus 2024 Abstracts On-Demand 2024

Novel pVAD-assisted complex CTO-PCI in a patient with reduced left ventricular ejection fraction

Presenter: Jurij Avramovic

February 02, 2024

News Conference News STS 2024

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Yael L. Maxwell

February 01, 2024

Advertisement

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

TCT 1220: Sequential PCI of a CTO LAD: Investment Procedure

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

TCT 1217: LM-LAD PCI in Subacute Anterior STEMI Complicated With Periprocedural Cardiac Arrest Supported With Novel pVAD

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

National Data Point to Soaring TAVI Rates in Patients Under 65

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

Medical Management Post AVR

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

SAVR After Failed TAVI on the Rise, With High Mortality

Successful CTO LCX PCI with massive periprocedural cardiac tamponade

Novel pVAD-assisted complex CTO-PCI in a patient with reduced left ventricular ejection fraction

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content